| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-20 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-12 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-12 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-11 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.32 | 4e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |